609 related articles for article (PubMed ID: 20490627)
41. Polymer microneedles for controlled-release drug delivery.
Park JH; Allen MG; Prausnitz MR
Pharm Res; 2006 May; 23(5):1008-19. PubMed ID: 16715391
[TBL] [Abstract][Full Text] [Related]
42. Characterization of microchannels created by metal microneedles: formation and closure.
Kalluri H; Kolli CS; Banga AK
AAPS J; 2011 Sep; 13(3):473-81. PubMed ID: 21732220
[TBL] [Abstract][Full Text] [Related]
43. Two-Photon Polymerisation 3D Printing of Microneedle Array Templates with Versatile Designs: Application in the Development of Polymeric Drug Delivery Systems.
Cordeiro AS; Tekko IA; Jomaa MH; Vora L; McAlister E; Volpe-Zanutto F; Nethery M; Baine PT; Mitchell N; McNeill DW; Donnelly RF
Pharm Res; 2020 Aug; 37(9):174. PubMed ID: 32856172
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of geometrical effects of microneedles on skin penetration by CT scan and finite element analysis.
Loizidou EZ; Inoue NT; Ashton-Barnett J; Barrow DA; Allender CJ
Eur J Pharm Biopharm; 2016 Oct; 107():1-6. PubMed ID: 27373753
[TBL] [Abstract][Full Text] [Related]
45. An overview on the advantages and limitations of 3D printing of microneedles.
Ozyilmaz ED; Turan A; Comoglu T
Pharm Dev Technol; 2021 Nov; 26(9):923-933. PubMed ID: 34369288
[TBL] [Abstract][Full Text] [Related]
46. Microneedle penetration and injection past the stratum corneum in humans.
Sivamani RK; Stoeber B; Liepmann D; Maibach HI
J Dermatolog Treat; 2009; 20(3):156-9. PubMed ID: 19016065
[TBL] [Abstract][Full Text] [Related]
47. Microneedles assisted controlled and improved transdermal delivery of high molecular drugs via
Khan S; Minhas MU; Singh Thakur RR; Aqeel MT
Drug Dev Ind Pharm; 2022 Jun; 48(6):265-278. PubMed ID: 35899871
[TBL] [Abstract][Full Text] [Related]
48. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery.
Park JH; Allen MG; Prausnitz MR
J Control Release; 2005 May; 104(1):51-66. PubMed ID: 15866334
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of microneedles-assisted in situ depot forming poloxamer gels for sustained transdermal drug delivery.
Khan S; Minhas MU; Tekko IA; Donnelly RF; Thakur RRS
Drug Deliv Transl Res; 2019 Aug; 9(4):764-782. PubMed ID: 30675693
[TBL] [Abstract][Full Text] [Related]
50. Engineering and characterisation of BCG-loaded polymeric microneedles.
Arshad MS; Fatima S; Nazari K; Ali R; Farhan M; Muhammad SA; Abbas N; Hussain A; Kucuk I; Chang MW; Mehta P; Ahmad Z
J Drug Target; 2020 Jun; 28(5):525-532. PubMed ID: 31718314
[TBL] [Abstract][Full Text] [Related]
51. Chitosan microneedle patches for sustained transdermal delivery of macromolecules.
Chen MC; Ling MH; Lai KY; Pramudityo E
Biomacromolecules; 2012 Dec; 13(12):4022-31. PubMed ID: 23116140
[TBL] [Abstract][Full Text] [Related]
52. Fabrication and characterisation of self-applicating heparin sodium microneedle patches.
Arshad MS; Zafar S; Zahra AT; Zaman MH; Akhtar A; Kucuk I; Farhan M; Chang MW; Ahmad Z
J Drug Target; 2021 Jan; 29(1):60-68. PubMed ID: 32649227
[TBL] [Abstract][Full Text] [Related]
53. The Troy Microneedle: A Rapidly Separating, Dissolving Microneedle Formed by Cyclic Contact and Drying on the Pillar (CCDP).
Kim M; Yang H; Kim S; Lee C; Jung H
PLoS One; 2015; 10(8):e0136513. PubMed ID: 26308945
[TBL] [Abstract][Full Text] [Related]
54. Controllable coating of microneedles for transdermal drug delivery.
Chen J; Qiu Y; Zhang S; Yang G; Gao Y
Drug Dev Ind Pharm; 2015 Mar; 41(3):415-22. PubMed ID: 24378200
[TBL] [Abstract][Full Text] [Related]
55. Fabrication and Evaluation of Transdermal Microneedles for a Recombinant Human Keratinocyte Growth Factor.
Chellathurai MS; Ling VWT; Palanirajan VK
Turk J Pharm Sci; 2021 Feb; 18(1):96-103. PubMed ID: 33634684
[TBL] [Abstract][Full Text] [Related]
56. Processing difficulties and instability of carbohydrate microneedle arrays.
Donnelly RF; Morrow DI; Singh TR; Migalska K; McCarron PA; O'Mahony C; Woolfson AD
Drug Dev Ind Pharm; 2009 Oct; 35(10):1242-54. PubMed ID: 19555249
[TBL] [Abstract][Full Text] [Related]
57. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the effect of polymeric microneedle arrays of varying geometries in combination with a high-velocity applicator on skin permeability and irritation.
Watanabe T; Hagino K; Sato T
Biomed Microdevices; 2014 Aug; 16(4):591-7. PubMed ID: 24733417
[TBL] [Abstract][Full Text] [Related]
59. Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo.
Vicente-Perez EM; Larrañeta E; McCrudden MTC; Kissenpfennig A; Hegarty S; McCarthy HO; Donnelly RF
Eur J Pharm Biopharm; 2017 Aug; 117():400-407. PubMed ID: 28478160
[TBL] [Abstract][Full Text] [Related]
60. IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery.
Mönkäre J; Reza Nejadnik M; Baccouche K; Romeijn S; Jiskoot W; Bouwstra JA
J Control Release; 2015 Nov; 218():53-62. PubMed ID: 26437262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
